Based on the finding that hematological cancer cell lines were more sensitive to cPLA2α inhibition than solid cancer cell lines, we next explored PLA2G4A gene expression in different cancers of blood origin. Here, PLA2G4A is linked to hematopoietic and lymphoid cell neoplasm.